Will rasagiline treatment cause unsteady walking? Common motor incoordination problems among patients

Rasagiline (Rasagiline) is a monoamine oxidaseB (MAO-B) inhibitor commonly used to treat Parkinson's disease. As a drug, rasagiline can improve motor symptoms in people with Parkinson's disease by increasing dopamine levels in the brain. However, like many medications, rasagiline use may cause some side effects, including problems with movement coordination and unsteady walking. Although rasagiline is safe and effective in most patients, some patients may experience adverse effects during treatment, particularly those related to motor coordination.

Parkinson's disease itself is a neurological disease characterized by movement dysfunction, manifested by tremor, stiffness, bradykinesia and unsteady gait. Rasagiline helps improve these motor symptoms by increasing the effects of dopamine, but in some cases the drug may worsen motor incoordination. Particularly when patients are more severely ill or are taking other medications for Parkinson's disease (such as levodopa), rasagiline may interact with these medications, causing fluctuations or worsening of symptoms. For example, excessively increased dopamine activity may cause patients to develop dyskinesia, characterized by involuntary rapid movements.

Although rasagiline itself is relatively safe, it can cause some side effects, including problems with movement coordination. Patients may experience unsteady walking, stiffness, or uncoordinated movements, especially during the initial stages of drug treatment or when adjusting dosage. These symptoms are often related to the dopamine-potentiating effects of drugs, as fluctuations in dopamine levels may affect the normal function of the nervous system, leading to abnormal motor control. Elderly patients, in particular, may be more sensitive to medications due to decline in their nervous systems.

Rasagiline is often used with other anti-Parkinsonian drugs, most commonly levodopa. However, levodopa itself may also cause incoordination, especially dyskinesias after prolonged use. When rasagiline is used in combination with levodopa, this side effect may be aggravated, leading to unsteady walking and limb control problems, if the dosage is inappropriate or the patient is overly sensitive to the drug. In this case, the patient may experience unsteady gait or sudden loss of movement, so the patient's treatment plan needs to be regularly evaluated and medication dosage adjusted based on symptoms.

Reference materials:https://www.azilect.com/